Network meta-analysis of long-term efficacy of acupuncture-related therapies and SSRIs in treating post-stroke depression

• 作者: Fan-Jie Xiong Wei Zhao Kai Song Hong Zhang
• 来源期刊: 海南医科大学学报（英文版）
• 年，卷（期）: 2021,（17）
• 所属期刊栏目: Original article
• 页码范围: 39-46
• 页数: 8页
• 语种: 英文

摘要

Objective: To evaluate the effect of existing acupuncture-related therapies on the long-term effects of post-stroke depression (PSD) by using a network meta-analysis with SSRIs as a common reference. Methods: The published randomized controlled clinical trials of acupuncture-related therapies and SSRIs for PSD in PubMed, The Cochrane Library, EMbase, CNKI, CBM, VIP and wan-fang databases were comprehensively searched. The literature retrieval period was from The database establishment to July 31, 2020. Cochrane Handbook 5.1.0 was used to assess the risk of bias in included studies. Data analysis is conducted through ADDIS, Review Manager 5.3, and STATA 13.1 software. Results: A total of 3115 patients with PSD were included in 30 RCTs, involving 10 therapeutic methods. Results of network meta-analysis showed that: in terms of total effective rate, body acupuncture +SSRIs was superior to body acupuncture [OR=2.85, 95％CI (1.51, 5.90)] and SSRIs[OR=5.37, 95％CI (3.03, 10.33)]. In terms of HAMD score, body acupuncture +SSRIs was superior to body acupuncture [MD=1.69, 95％CI(0.33, 3.06)] and SSRIs[MD=3.87, 95％ CI(2.68, 5.08)]. The above ranking predicted that moxibustion +SSRIs was the best. In terms of NIHSS score, body acupuncture [MD=2.15, 95％ CI(1.10, 3.26)] and body acupuncture +SSRIs[MD=1.77, 95％CI(0.19, 3.37)] were better than SSRIs. Conclusion: Moxibustion combined with SSRIs is the best for the long-term efficacy of acupuncture and moxibustion on PSD. Body acupuncture combined with SSRIs is better than SSRIs alone. The other therapies have their own advantages and disadvantages. Based on the defects of existing studies, this conclusion still needs to be verified by more high-quality RCTs.